<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2079-5696</issn><issn publication-format="electronic">2079-5831</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">50859</article-id><article-id pub-id-type="doi">10.26442/20795696.2020.5.200423</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОР</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Omega-3 polyunsaturated fatty acids in supporting pregnancy and fetal development: dosing considerations</article-title><trans-title-group xml:lang="ru"><trans-title>Омега-3-полиненасыщенные жирные кислоты в поддержке беременности и развития плода: вопросы дозирования</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><contrib-id contrib-id-type="scopus">7003589812</contrib-id><contrib-id contrib-id-type="spin">6317-9833</contrib-id><name-alternatives><name xml:lang="en"><surname>Gromova</surname><given-names>Olga A.</given-names></name><name xml:lang="ru"><surname>Громова</surname><given-names>Ольга Алексеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof., Federal Research Center “Informatics and Management”</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф., вед. науч. сотр., науч. рук. Института фармакоинформатики ФИЦ ИУ РАН</p></bio><email>unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><contrib-id contrib-id-type="scopus">7003300274</contrib-id><contrib-id contrib-id-type="spin">1375-1114</contrib-id><name-alternatives><name xml:lang="en"><surname>Torshin</surname><given-names>Ivan Iu.</given-names></name><name xml:lang="ru"><surname>Торшин</surname><given-names>Иван Юрьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Chem.), Federal Research Center “Informatics and Management”</p></bio><bio xml:lang="ru"><p>канд. хим. наук, ст. науч. сотр. Института фармакоинформатики ФИЦ ИУ РАН</p></bio><email>unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1665-1188</contrib-id><name-alternatives><name xml:lang="en"><surname>Grishina</surname><given-names>Tatiana R.</given-names></name><name xml:lang="ru"><surname>Гришина</surname><given-names>Татьяна Романовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof., Ivanovo State Medical Academy</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф., зав. каф. фармакологии ФГОУ ВО ИвГМА</p></bio><email>unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2521-0824</contrib-id><contrib-id contrib-id-type="spin">6257-4400</contrib-id><name-alternatives><name xml:lang="en"><surname>Maliavskaia</surname><given-names>Svetlana I.</given-names></name><name xml:lang="ru"><surname>Малявская</surname><given-names>Светлана Ивановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof., Northern State Medical University</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф., проректор по научной работе ФГБОУ ВО СГМУ</p></bio><email>unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Research Center “Informatics and Management”</institution></aff><aff><institution xml:lang="ru">Федеральный исследовательский центр «Информатика и управление» РАН</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Ivanovo State Medical Academy</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Ивановская государственная медицинская академия» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Northern State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Северный государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-11-23" publication-format="electronic"><day>23</day><month>11</month><year>2020</year></pub-date><volume>22</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>61</fpage><lpage>69</lpage><history><date date-type="received" iso-8601-date="2020-11-22"><day>22</day><month>11</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-11-22"><day>22</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://gynecology.orscience.ru/2079-5831/article/view/50859">https://gynecology.orscience.ru/2079-5831/article/view/50859</self-uri><abstract xml:lang="en"><p>Being complex regulators of inflammation processes omega-3-polyunsaturated fatty acids (PUFAs) are vitally important for supporting pregnancy and fetal development. Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are the most important omega-3-PUFAs. The article presents the results of a systematic analysis of 1973 studies of dose-dependent effects of DHA and EPA in nutritional support of pregnancy. The analysis results suggest that DHA/EPA donations for pregnant women are effective only in doses of at least 200 mg/day. According to the analysis results, the optimal doses of DHA/EPA are in the 400- to 800-mg/day range. The dose of omega-3-PUFA for a particular patient can be assessed by the measurement of the DHA and EPA levels in the erythrocyte membrane. To achieve specific therapeutic effects (for example, lowering triglyceride levels, therapy for postpartum depression, etc.), higher doses of omega-3-PUFAs (3–5 g/day) may be required. With an adequate choice of dosing regimen, DHA / EPA donations have a beneficial effect on the somatic health of women of reproductive age, help to prevent pregnancy complications and determine the child development program in the subsequent years of life. DHA/EPA drugs are effective in the adjuvant therapy of various chronic disorders.</p></abstract><trans-abstract xml:lang="ru"><p>Омега-3-полиненасыщенные жирные кислоты (ПНЖК), являясь комплексными регуляторами процессов воспаления, принципиально важны для поддержки беременности и развития плода. Докозагексаеновая кислота (ДГК) и эйкозапентаеновая кислота (ЭПК) являются наиболее важными представителями омега-3-ПНЖК. Представлены результаты систематического анализа 1973 исследований дозозависимых эффектов ДГК и ЭПК в нутрициальной поддержке беременности. Результаты анализа позволяют утверждать, что дотации ДГК/ЭПК беременным эффективны только в дозах не менее 200 мг/сут. В соответствии с результатами проведенного анализа оптимальными представляются дозы ДГК/ЭПК в диапазоне 400–800 мг/сут. Доза омега-3-ПНЖК для конкретного пациента может быть оценена на основании измерений уровней ДГК и ЭПК в мембранах эритроцитов. Для достижения специфических терапевтических эффектов (например, снижения уровней триглицеридов, терапии послеродовой депрессии и др.) могут потребоваться более высокие дозы омега-3-ПНЖК (3–5 г/сут). При адекватном выборе режима дозирования дотации ДГК/ЭПК положительно влияют на соматическое здоровье женщин репродуктивного возраста, способствуют профилактике осложнений беременности и определяют программу развития ребенка в последующие годы жизни. Препараты ДГК/ЭПК эффективны в адъювантной терапии различных хронических патологий.</p></trans-abstract><kwd-group xml:lang="en"><kwd>docosahexaenoic acid</kwd><kwd>eicosapentaenoic acid</kwd><kwd>dosing</kwd><kwd>pregnancy</kwd><kwd>intrauterine development</kwd><kwd>9 Mesiatsev Omegamama</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>докозагексаеновая кислота</kwd><kwd>эйкозапентаеновая кислота</kwd><kwd>дозирование</kwd><kwd>беременность</kwd><kwd>внутриутробное развитие</kwd><kwd>9 месяцев Омегамама</kwd></kwd-group><funding-group><funding-statement xml:lang="en">the Russian Foundation for Basic Research, project No. 20-07-00537</funding-statement><funding-statement xml:lang="ru">Российский фонд фундаментальных исследований, проект №20-07-00537</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Громова О.А., Торшин И.Ю., Захарова И.Н. и др. Омега-3- полиненасыщенные жирные кислоты: природные источники и значение в педиатрической практике. РМЖ. 2017; 25 (11): 836–42. [Gromova O.A., Torshin I.Iu., Zakharova I.N. et al. Omega-3 polinenasyshchennye zhirnye kisloty: prirodnye istochniki i znachenie v pediatricheskoi praktike. RMZh. 2017; 25 (11): 836–42 (in Russian).]</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Громова О.А., Торшин И.Ю., Лиманова О.А., Серов В.Н. О профилактической, лечебной и избыточной дозе омега-3-полиненасыщенных жирных кислот в прегравидарный период, во время беременности и кормления грудью. Эффективная фармакотерапия. 2014; 45: 28–37. [Gromova O.A., Torshin I.Iu., Limanova O.A., Serov V.N. O profilakticheskoi, lechebnoi i izbytochnoi doze omega-3 polinenasyshchennykh zhirnykh kislot v pregravidarnyi period, vo vremia beremennosti i kormleniia grud’iu. Effektivnaia farmakoterapiia. 2014; 45: 28–37 (in Russian).]</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Richter CK, Bowen KJ, Mozaffarian D et al. Total Long-Chain n-3 Fatty Acid Intake and Food Sources in the United States Compared to Recommended Intakes: NHANES 2003–2008. Lipids 2017; 52 (11): 917–27. DOI: 10.1007/s11745-017-4297-3</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Liu MJ, Li HT, Yu LX et al. A Correlation Study of DHA Dietary Intake and Plasma, Erythrocyte and Breast Milk DHA Concentrations in Lactating Women from Coastland, Lakeland, and Inland Areas of China. Nutrients 2016; 8 (5): 312. DOI: 10.3390/nu8050312</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Forsyth S, Gautier S, Salem N Jr. Estimated Dietary Intakes of Arachidonic Acid and Docosahexaenoic Acid in Infants and Young Children Living in Developing Countries. Ann Nutr Metab 2016; 69 (1): 64–74. DOI: 10.1159/000448526</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Muthayya S, Dwarkanath P, Thomas T et al. The effect of fish and omega-3 LCPUFA intake on low birth weight in Indian pregnant women. Eur J Clin Nutr 2009; 63 (3): 340–6. DOI: 10.1038/sj.ejcn.160293317957193</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Лиманова О.А., Громова О.А., Волков А.Ю. и др. Низкое потребление омега-3-ПНЖК полиненасыщенных жирных кислот и риск различных заболеваний у женщин репродуктивного возраста. РМЖ. 2017; 10. https://www.rmj.ru/articles/ginekologiya/nizkoe-potreblenie-omega-3-polinenasyshchennykh-zhirnykh-kislot-i-risk-razlichnykh-zabolevaniy-u-zhe/. [Limanova O.A., Gromova O.A., Volkov A.Iu. et al. Nizkoe potreblenie omega-3 PNZhK polinenasyshchennykh zhirnykh kislot i risk razlichnykh zabolevanii u zhenshchin reproduktivnogo vozrasta. RMZh. 2017; 10. https://www.rmj.ru/articles/ginekologiya/nizkoe-potreblenie-omega-3-polinenasyshchennykh-zhirnykh-kislot-i-risk-razlichnykh-zabolevaniy-u-zhe/et al (in Russian).]</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Torshin IY, Rudakov KV. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. Part 1: factorization approach. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2017; 27 (1): 16−28. DOI: 10.1134/S1054661817010151</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Torshin IYu, Rudakov KV. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. Part 2: metric approach within the framework of the theory of classification of feature values. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2017; 27 (2): 184−99. DOI: 10.1134/S1054661817020110</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Torshin IY. Optimal dictionaries of the final information on the basis of the solvability criterion and their applications in bioinformatics. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2013; 23 (2): 319−27. DOI: 10.1134/S1054661813020156</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Torshin IYu, Rudakov KV. On metric spaces arising during formalization of problems of recognition and classification. Part 2: density properties. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2016; 26 (3): 483−96. DOI: 10.1134/S1054661816030202</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Torshin IYu, Rudakov KV. On the Procedures of Generation of Numerical Features Over Partitions of Sets of Objects in the Problem of Predicting Numerical Target Variables. Pattern Recognition and Image Analysis. 2019; 29 (4): 654–67. DOI: 10.1134/S1054661819040175</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Maki KC, Yurko-Mauro K, Dicklin MR et al. A new, microalgal DHA- and EPA-containing oil lowers triacylglycerols in adults with mild-to-moderate hypertriglyceridemia. Prostaglandins Leukot Essent Fatty Acids 2014; 91 (4): 141–8. DOI: 10.1016/j.plefa.2014.07.012</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>AbuMweis SS, Panchal SK, Jones PJH. Triacylglycerol-Lowering Effect of Docosahexaenoic Acid Is Not Influenced by Single-Nucleotide Polymorphisms Involved in Lipid Metabolism in Humans. Lipids 2018. DOI: 10.1002/lipd.12096</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Sparkes C, Gibson R, Sinclair A et al. Effect of Low Dose Docosahexaenoic Acid-Rich Fish Oil on Plasma Lipids and Lipoproteins in Pre-Menopausal Women: A Dose-Response Randomized Placebo-Controlled Trial. Nutrients 2018; 10 (10). DOI: 10.3390/nu10101460</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Sahebkar A, Simental-Mendia LE, Mikhailidis DP et al. Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials. Ann Med 2018: 1–11. DOI: 10.1080/07853890.2018.1511919</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lopez-Huertas E. The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials. Br J Nutr 2012; 107 (Suppl. 2): S185–94. DOI: 10.1017/S0007114512001572</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Vericel E, Colas R, Calzada C et al. Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. Thromb Haemost 2015; 114 (2): 289–96. DOI: 10.1160/TH14-12-1003</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Громова О.А., Торшин И.Ю. Микронутриенты и репродуктивное здоровье. Руководство. М.: ГЭОТАР-Медиа, 2019. [Gromova O.A., Torshin I.Yu. Micronutrients and reproductive health. Guide. Moscow: GEOTAR-Media, 2019 (in Russian).]</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Торшин И.Ю., Громова О.А., Кобалава Ж.Д. О репрессиях w-3 полиненасыщенных жирных кислот адептами доказательной медицины. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2019; 12 (2): 91–114. DOI: 10.17749/2070-4909.2019.12.2.91-114 [Torshin I.Yu., Gromova O.A., Kobalava Zh.D. Concerning the “repression” of w-3 polyunsaturated fatty acids by adepts of evidencebased medicine. FARMAKOEKONOMIKA. Modern pharmacoeconomic and pharmacoepidemiology. 2019; 12 (2): 91–114. DOI: 10.17749/2070-4909.2019.12.2.91-114 (in Russian).]</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Borges MC, Schmidt AF, Jefferis B et al. Circulating Fatty Acids and Risk of Coronary Heart Disease and Stroke: Individual Participant Data Meta-Analysis in Up to 16 126 Participants. J Am Heart Assoc 2020; 9 (5): e013131. DOI: 10.1161/JAHA.119.013131. PubMed PMID: 32114887.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Marston NA, Giugliano RP, Im K et al. Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials. Circulation 2019; 140 (16): 1308–17. DOI: 10.1161/CIRCULATIONAHA.119.041998. PubMed PMID: 31530008; PMCID: PMC6791781.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hodson L, Bhatia L, Scorletti E et al. Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study. Eur J Clin Nutr 2017; 71 (8): 973–9. DOI: 10.1038/ejcn.2017.9</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Wang F, Wang Y, Zhu Y et al. Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial. Eur J Nutr 2017; 56 (7): 2415–22. DOI: 10.1007/s00394-016-1352-4. PubMed PMID 27913872.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Jacobo-Cejudo MG, Valdés-Ramos R, Guadarrama-López AL et al. Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients. Nutrients 2017; 9 (6): 573. DOI: 10.3390/nu9060573. PubMed PMID 28587203.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Cruz-Hernandez C, Destaillats F, Thakkar SK et al. Monoacylglycerol-enriched oil increases EPA/DHA delivery to circulatory system in humans with induced lipid malabsorption conditions. J Lipid Res 2016; 57 (12): 2208–16. DOI: 10.1194/jlr.P070144</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Becic T, Studenik C. Effects of Omega-3 Supplementation on Adipocytokines in Prediabetes and Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Metab J 2018; 42 (2): 101–16. DOI: 10.4093/dmj.2018.42.2.101. PubMed PMID: 29676540; PMCID: PMC5911513.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Chinnery HR, Naranjo Golborne C, Downie LE. Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study. Ophthalmic Physiol Opt 2017; 37 (4): 473–81. DOI: 10.1111/opo.12365. PubMed PMID 28295445.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Bozzatello P, Brignolo E, De Grandi E, Bellino S. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J Clin Med 2016; 5 (8). DOI: 10.3390/jcm5080067</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003; 13 (4): 267–71</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Zhang MM, Zou Y, Li SM et al. The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials. Transl Psychiatry 2020; 10 (1): 193. DOI: 10.1038/s41398-020-00886-3. PubMed PMID: 32555188; PMCID: PMC7299975.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Harris MA, Reece MS, McGregor JA et al. The Effect of Omega-3 Docosahexaenoic Acid Supplementation on Gestational Length: Randomized Trial of Supplementation Compared to Nutrition Education for Increasing n-3 Intake from Foods. Biomed Res Int 2015: 123078. DOI: 10.1155/2015/123078</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Prado EL, Ashorn U, Phuka J et al. Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving. Matern Child Nutr 2018; 14 (2): e12546. DOI: 10.1111/mcn.12546. PubMed PMID 29098783.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Arvizu M, Afeiche MC, Hansen S et al. Fat intake during pregnancy and risk of preeclampsia: a prospective cohort study in Denmark. Eur J Clin Nutr 2019; 73 (7). DOI: 10.1038/s41430-018-0290-z</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Bakouei F, Delavar MA, Mashayekh-Amiri S et al. Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced- hypertension or preeclampsia: A systematic review and meta-analysis. Taiwan J Obstet Gynecol 2020; 59 (1): 8–15. DOI: 10.1016/j.tjog.2019.11.002. PubMed PMID: 32039806.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Stoutjesdijk E, Schaafsma A, Dijck-Brouwer DAJ, Muskiet FAJ. Fish oil supplemental dose needed to reach 1g% DHA+EPA in mature milk. Prostaglandins Leukot Essent Fatty Acids 2018; 128: 53–61. DOI: 10.1016/j.plefa.2017.11.003</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Deng J, Li X, Ding Z, Wu Y et al. Effect of DHA supplements during pregnancy on the concentration of PUFA in breast milk of Chinese lactating mothers. J Perinat Med 2017; 45 (4): 437–41. DOI: 10.1515/jpm-2015-0438</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Gustafson KM, Carlson SE, Colombo J et al. Effects of docosahexaenoic acid supplementation during pregnancy on fetal heart rate and variability: a randomized clinical trial.Prostaglandins Leukot Essent Fatty Acids 2013; 88 (5): 331–8. DOI: 10.1016/j.plefa.2013.01.009</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Granot E, Jakobovich E, Rabinowitz R et al. DHA supplementation during pregnancy and lactation affects infants’ cellular but not humoral immune response. Mediators Inflamm 2011: 493925. DOI: 10.1155/2011/493925</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Ramakrishnan U, Stein AD, Parra-Cabrera S et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull 2010; 31 (Suppl. 2): S108–16. DOI: 10.1177/15648265100312S203</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Mulder KA, King DJ, Innis SM. Omega-3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy.PLoS One 2014; 9 (1): e83764. DOI: 10.1371/journal.pone.0083764</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Shulkin M, Pimpin L, Bellinger D et al. N-3 Fatty Acid Supplementation in Mothers, Preterm Infants, and Term Infants and Childhood Psychomotor and Visual Development: A Systematic Review and Meta-Analysis. J Nutr 2018; 148 (3): 409–18. DOI: 10.1093/jn/nxx031. PubMed PMID: 29546296; PMCID: PMC6251555.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Торшин И.Ю., Громова О.А., Зайчик Б.Ц., Ружицкий А.О. Комплексное исследование состава экстрактов жира рыб и количественные критерии для различения стандартизированных экстрактов омега-3-полиненасыщенных жирных кислот. Кардиология. 2020; 60 (5): 1–10. DOI: 10.18087/cardio.2020.5.n1053 [Torshin I.Yu., Gromova O.A., Zaychik B.Ts., Ruzhitsky A.O. Comprehensive study of the compositionof fish fat extracts and quantitative criteria for distinguishing standardized omega-3 polyunsaturated fatty acids extracts. Kardiologiia. 2020; 60 (5): 1–10. DOI: 10.18087/cardio.2020.5.n1053 (in Russian).]</mixed-citation></ref></ref-list></back></article>
